โ† All deals

REGENERON PHARMACEUTICALS, INC.

Public Equity (NASDAQ)BiotechnologyPublic CompanyB2B
๐Ÿ“ Tarrytown, New York, United Statesโ€ข 15410 employees
StreetZero Signal 60
Be the first to signal interest

About REGENERON PHARMACEUTICALS, INC.

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The company operates as a public B2B entity in the biotechnology sector with headquarters in Tarrytown, New York. It maintains a significant online presence with over 692,000 LinkedIn followers and has completed multiple funding rounds including grants and post-IPO equity.

LATEST FUNDINGRule 144
$958K
Announced 2026-11-17
TOTAL RAISED$719.15M
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for REGENERON PHARMACEUTICALS, INC..

Free plan includes 3 full deal profiles every month.

Key highlights

  • Completed Post-IPO Equity round of $2.03M in July 2024.
  • Total historical funding reaches $719.15M including multiple grants.
  • Publicly traded on NASDAQ under ticker REGN with market cap exceeding $95B.
  • Employs 15,410 people and generates $16.9B in annual revenue.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account